In the present study, we explored the role of miR-146a in NSCLC, using five cell lines, one with a KRAS mutation and EGFR wild type (H358), one with KRAS and EGFR wild type (H292), and three cell lines with a EGFR kinase domain mutation. Here, KRAS is linked to non-small cell lung carcinoma.